Skip to main content
. 2021 Dec 4;13(23):6117. doi: 10.3390/cancers13236117

Figure 5.

Figure 5

MPT0L145 sensitized cancer cells to abemaciclib. The three cancer cells were treated with the indicated concentrations of abemaciclib in the absence or presence of the indicated concentrations (μM) of MPT0L145 for 72 h and subjected to MTT assay. Data are presented as the mean ± SD of duplicate wells and are representative of three independent experiments. Abe: abemaciclib. L145: MPT0L145. (* p < 0.05, ** p < 0.01 compared to control group, # p < 0.05, ## p < 0.01 compared to indicated concentrations of abemaciclib).